Tag: ACHN

Blue Horseshoe Stocks: CANV, ACHN, FREE & More

CannaVest Corp. CANV 

CANV is a stock that recently fell off of a cliff, and found itself trading at 52-week lows.  We like to monitor such plays during their recovery, which has already begun in this case. Trading near its annual lows, CANV appears undervalued, especially in light of the figures contained in the earnings report put out by the company yesterday.

Highlights included a Q2 net income of slightly over $8M, as compared to a net loss of $348K for the same quarter in 2013, and over $9M in cash on-hand. We suggest you read the release in its entirety >>> FULL PR

Check out these websites for some background on Cannavest (http://www.CannaVest.com) and its subsidiaries, which include US Hemp Oil, LLC (http://www.USHempOil.com), and CannaVest Laboratories, LLC (http://www.CannaVestLabs.com).. We’re always interested tracking a revenue-generating company in the cannabis sector, and CANV fits the bill.

The stock was trading as high as $20.00 just a few months ago; regaining even a portion of the ground it has lost from current prices in the mid-$3 range would mean the chance at a significant profit for nimble traders.

Achillion Pharmaceuticals, Inc. ACHN

ACHN is a stock we began to track earlier this summer (June 9th) as it was in the midst of a massive surge. At the time we caught it at a low of 3.72, and it ran to nearly $8 over just a two-session span. In the following months, it had been trading in a rough channel between the mid-$6’s and mid-$7’s, and just cracked over $8 yesterday for the first time in more than a year.

This morning’s PR regarding the company’s hepatitis C drug, which was been found to cure all patients in mid-stage trials is also contributing to a huge gap-up that has the stock pushing the $10 mark in the premarket. At that level, we’re already looking at a 168% move up from the the lows we observed in June, and we’re certainly going to have the stock on more intensive watch moving forward.


FreeSeas, Inc. FREE

After appearing in yesterday morning’s extended watchlist, FREE went on to break above the 50DMA at .66, and run 28% intraday from .631-.809.  We want to see higher highs and higher lows acheived as this is another play coming off of its 52-week lows. We’ll need to see it maintain support above the previous 50DMA of .66 in order to keep our attention.

The spike we’re seeing here comes in conjunction with yesterday’s announcement that FREE had regained compliance with Nasdaq’s minimum stockholders equity rule. >>> FULL PR

PBR Options Ideas:

Continuing our coverage of the PBR options chain, we wanted to throw out a few quick ideas as the week comes to a close. We may be interested in the August 22nd $15.50 and $16.00 Calls for a swing trade into next week.

Extended Watchlist:
USU, AMCF, MNDL, BDR, MGT, FSI

Blue Horseshoe Stocks: Another PBR Update & More

Petroleo Brasiliero S.A (Petrobras) PBR – Options

Petrobras continues to be one of our main conduits to making large gains. We were able to carve out another chunk of profits on Friday as the stock hit a new high for us, traversing its way up the chart to peak at 15.92. Considering we picked up on this play in the low $11-range shortly following its 10-year lows back in March, we’d call its performance since then nothing short of amazing.

Of course, our real bread and butter here has been the options chain. Last week was yet another victory for anyone playing the Call side, with every contract we were watching making some nice strides.

In particular, the 07/19 $15 Calls that we’ve been tracking for weeks now have done beautifully, hitting a new high on Friday at 1.25. From the 25-cent low we observed in the week prior, that marks a walloping 400% move!

As we’ve stated before, we will continue to stick with monitoring PBR for as long as it continues to serve us up ripe opportunities for profit.

BARCHART.COM is presently issuing PBR a 96% Overall “Buy Rating”


Intuitive Surgical, Inc. ISRG

ISRG comes back to us this morning as a play that we inserted into our running watchlist back at the beginning of May. On the 6th, we mentioned that the stock could provide us with “potential gains over the next several weeks,” and while it took awhile for things to get moving, that statement still stands.

One of our points of focus was on the ISRG chart were a pair of gap-downs that had transpired in recent weeks, and we’ll still be looking for a break of that first gap to get things started. Presently we’re looking at the Weekly $385-395 Calls for intraday flip opportunities, but if it appears we’re moving to fill the gap, we may need to roll our strike price up.

Provided ISRG does fill in the gap on the chart from roughly $400-415, over the longer-term we could find ourselves looking at The Aug.-Oct. $420-440 Calls.

Solar Wind Energy tower, Inc. SWET

We put SWET on our radar on Friday, and will continue to monitor the stock over the course of the week. The chart is exhibiting signs of ripening, and looks to still be right on the verge of potentially making a nice move, so we want to keep a sharp eye on the activity here as we kick off a new trading week.

The company released some news this morning about a cash infusion they’ve received, and we’re also going to look out for potential updates concerning SWET’s presenting at the NIBA (National Investment Banking Association) conference tomorrow (Tue. 17th).

Extended Watchlist:
FIO, DARA, ACHN, AKS, SQNM, LLNW, SA, ANV

Blue Horseshoe Stocks: ACHN, PBR & Extended Watchlist

Petroleo Brasiliero S.A. (Petrobras) PBR

PBR had another solid day yesterday, dipping below $15 only briefly where it found support at 14.88 before going on to push its upper limits over the course of the session, acvhieving a new high for us at 15.34.

All of the options contracts that we’ve been monitoring on PBR served up chances to gain a significant amount as the stock continued to bull its way north.

Even our longer-term idea, the 07/19 $15 Calls we’ve been tracking since last week from a low of .25 has already given us the triple-bagger we suggested it might in last Wednesday’s report. They closed out the day at .88, an overall move of 252% and it would appear they want to gap up along with PBR stock this morning, so we expect that figure to increase even further.

PBR has come a long way since we caught it coming off of 10-year lows back on March 21st. The stock itself has regained a lot of ground, coming from our observed low of 11.25 all the way up to current levels above $15. As we stated yesterday, if PBR has a tough time breaking through resistance at its previous swing high of 15.85, we’ll start to think about taking profits off of the table.

Achillion Pharmaceuticals, Inc. ACHN

We have to begin this morning by congratulating any of our readers who picked up on our coverage of ACHN yesterday, which allowed us the chance to make sizable gains for the second day in a row.

The stock gapped up as it did on Monday and continued to roll, trading in a range from 6.02 to 7.81 on the day, giving traders the opportunity to pocket close to 30% in profits intraday on inordinately high volume (To the tune of more than 22x the 3-month average).

From the low of 3.72 that we observed on Monday, the stock has already made a fantastic  110% move to the upside over the span of just two sessions.

The company put more news out this morning as well:

NEW HAVEN, Jun 11, 2014 (GLOBE NEWSWIRE via COMTEX) — Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) announced today that members of the senior management team will present a corporate overview at two upcoming investor conferences:– 2014 Wells Fargo Healthcare Conference on Wednesday, June 18, 2014 at 1:15 p.m. ET at the InterContinental Hotel in Boston, MA; and– JMP Health Care Conference 2014 on Tuesday, June 24, 2014 at 11:00 a.m. ET at the Westin New York Grand Central Hotel in New York, NY.

The live audio and subsequent archived webcasts of the Company’s presentations will be accessible from the Company’s investor relations website, http://ir.achillion.com.

Extended Watchlist:
NWBO, NAVB, BIOF, PEIX, END, XXII